These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25895005)

  • 1. Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.
    Allegretti JR; Barnes EL; Cameron A
    Inflamm Bowel Dis; 2015 May; 21(5):1089-97. PubMed ID: 25895005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease: A Case-controlled Cohort Study.
    Goetgebuer RL; Kreijne JE; Aitken CA; Dijkstra G; Hoentjen F; de Boer NK; Oldenburg B; van der Meulen AE; Ponsioen CIJ; Pierik MJ; van Kemenade FJ; de Kok IMCM; Siebers AG; Manniën J; van der Woude CJ; de Vries AC
    J Crohns Colitis; 2021 Sep; 15(9):1464-1473. PubMed ID: 33609353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study.
    Kim SC; Glynn RJ; Giovannucci E; Hernández-Díaz S; Liu J; Feldman S; Karlson EW; Schneeweiss S; Solomon DH
    Ann Rheum Dis; 2015 Jul; 74(7):1360-7. PubMed ID: 24618265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between cervical dysplasia and IBD: a large case-control study.
    Lees CW; Critchley J; Chee N; Beez T; Gailer RE; Williams AR; Shand AG; Arnott ID; Satsangi J
    Inflamm Bowel Dis; 2009 Nov; 15(11):1621-9. PubMed ID: 19618462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Pap smears in inflammatory bowel disease.
    Kane S
    Inflamm Bowel Dis; 2008 Aug; 14(8):1158-60. PubMed ID: 18266234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical dysplasia in immunosuppressed IBD women.
    Zabana Y; Barreiro M; Mañosa M; Lorenzo A; Cabré E; Domènech E
    Inflamm Bowel Dis; 2009 Dec; 15(12):1774. PubMed ID: 19145640
    [No Abstract]   [Full Text] [Related]  

  • 8. Suboptimal rates of cervical testing among women with inflammatory bowel disease.
    Long MD; Porter CQ; Sandler RS; Kappelman MD
    Clin Gastroenterol Hepatol; 2009 May; 7(5):549-53. PubMed ID: 18996498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study.
    Jara Fernández L; Ferrer JÁ; Pérez Calle JL; López Serrano P
    Rev Esp Enferm Dig; 2024 May; 116(5):292-293. PubMed ID: 37732357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening differences and risk of cervical cancer in inflammatory bowel disease.
    Hutfless S; Fireman B; Kane S; Herrinton LJ
    Aliment Pharmacol Ther; 2008 Sep; 28(5):598-605. PubMed ID: 18549465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papanicolaou smear findings in solid-organ transplant recipients compared with normal subjects according to the Bethesda 2001 system.
    Ok Atılgan A; Tepeoğlu M; Haberal AN; Durukan E; Kuşcu E; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():219-22. PubMed ID: 25894158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for high-grade squamous intraepithelial lesions or cervical cancer in chronic inflammatory bowel disease].
    Dujardin C; Balcaen T; Vanoost A; Chatelain D; Gondry J; Fumery M; Foulon A
    Gynecol Obstet Fertil Senol; 2024; 52(7-8):460-465. PubMed ID: 38266774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?
    Klumb EM; Araújo ML; Jesus GR; Santos DB; Oliveira AV; Albuquerque EM; Macedo JM
    J Clin Rheumatol; 2010 Jun; 16(4):153-7. PubMed ID: 20407390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
    Ariyaratnam J; Subramanian V
    Am J Gastroenterol; 2014 Feb; 109(2):163-9. PubMed ID: 24419479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment.
    Axelrad JE; Lichtiger S; Yajnik V
    World J Gastroenterol; 2016 May; 22(20):4794-801. PubMed ID: 27239106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
    Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors.
    van de Ven SEM; Derikx LAAP; Nagtegaal ID; van Herpen CM; Takes RP; Melchers WJG; Pierik M; van den Heuvel T; Verhoeven RHA; Hoentjen F; Nissen LHC
    Inflamm Bowel Dis; 2020 Jun; 26(7):1060-1067. PubMed ID: 31559415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.
    Feldman CH; Liu J; Feldman S; Solomon DH; Kim SC
    Lupus; 2017 Jun; 26(7):682-689. PubMed ID: 27799438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study.
    Brunner A; Kruis W; Schömig-Markiefka B; Morgenstern J; Engels M; Büttner R; Forner DM
    J Cancer Res Clin Oncol; 2022 Nov; 148(11):3071-3079. PubMed ID: 34981194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.